Ovarian Cancer

Category

Kaiser Permanente Participating in AbbVie-Sponsored International Clinical Trial Targeting Ovarian Cancer with PARP Inhibitor Called Veliparib

Kaiser Permanente Research radio recently interviewed Dr. Michael A Bookman, an oncologist and investigator with Kaiser, discussing his participation in an international clinical trial sponsored by AbbVie, focusing on a PARP inhibitor called Veliparib to treat ovarian...

University of California San Diego School of Medicine Researchers Make Important Findings Surrounding FAK & Ovarian Cancer

The protein focal adhesion kinase, or FAK, is already recognized a key factor in helping tumors spread, but Researchers at the University of California San Diego School of Medicine have made another discovery surrounding this protein. Reported in UC San Diego Health,...

A Chinese Meta-Analysis and Mendelian Randomization Study Reveals Age of Menarche & Epithelial Ovarian Cancer Risk

The Tianjin Key Laboratory of Cancer Prevention and Therapy, part of the Department of Epidemiology and Biostatistics for the National Clinical Research Center for Cancer of Tianjin Medical University Cancer Institute and Hospital led a meta-analysis and Mendelian...

Pin It on Pinterest